Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA-Reference-Cited by-同舟云学术

Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA

Published:2021-11 Issue:7 Volume:1 Page:100106
ISSN:2667-2375
Container-title:Cell Reports Methods
language:en
Short-container-title:Cell Reports Methods

Author:

Willey James C.^ORCID,Morrison Tom B.,Austermiller Bradley,Crawford Erin L.^ORCID,Craig Daniel J.^ORCID,Blomquist Thomas M.,Jones Wendell D.^ORCID,Wali Aminah,Lococo Jennifer S.,Haseley Nathan,Richmond Todd A.,Novoradovskaya Natalia,Kusko Rebecca^ORCID,Chen Guangchun,Li Quan-Zhen,Johann Donald J.,Deveson Ira W.,Mercer Timothy R.,Wu Leihong,Xu Joshua^ORCID

Funder

Cancer Institute NSW

U.S. Food and Drug Administration

National Human Genome Research Institute

National Cancer Institute

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

General Medicine

Reference44 articles.

1. Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing;Abelson;Sci. Adv.,2020